Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Olschewski

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2016
[Pulmonary hypertension due to chronic lung disease: Recommendations of the Cologne Consensus Conference 2016]H Olschewski, J Behr, H Bremer, et al.
Deutsche Medizinische Wochenschrift (1946)|December 10, 2014
[Imatinib for pulmonary arterial hypertension]M M Hoeper, C Opitz, H Olschewski, et al.
Journal of Medical Genetics|December 20, 2003
Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasiaR E Harrison, J A Flanagan, M Sankelo, et al.
Deutsche Medizinische Wochenschrift (1946)|September 24, 2010
[Treatment of pulmonary arterial hypertension (PAH): recommendations of the Cologne Consensus Conference 2010]H A Ghofrani, O Distler, F Gerhardt, et al.
Pneumologie (Stuttgart, Germany)|December 19, 2001
[Recommendations for the choice of inhalatory systems for drug prescription]T Voshaar, E M App, D Berdel, et al.
Deutsche Medizinische Wochenschrift (1946)|December 10, 2014
[Supportive therapy in pulmonary arterial hypertension]E Grünig, N Ehlken, W Hohenforst-Schmidt, et al.
Deutsche Medizinische Wochenschrift (1946)|December 10, 2014
[Targeted therapy of pulmonary arterial hypertension (PAH)]H Klose, C Opitz, H Bremer, et al.
Wiener Klinisches Magazin : Beilage Zur Wiener Klinischen Wochenschrift|May 20, 2020
[Statement of the Austrian Society of Pneumology (ASP)]H Flick, B M Arns, J Bolitschek, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2016
[Pulmonary hypertension due to chronic lung disease: Recommendations of the Cologne Consensus Conference 2016]H Olschewski, J Behr, H Bremer, et al.
Deutsche Medizinische Wochenschrift (1946)|December 10, 2014
[Imatinib for pulmonary arterial hypertension]M M Hoeper, C Opitz, H Olschewski, et al.
Journal of Medical Genetics|December 20, 2003
Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasiaR E Harrison, J A Flanagan, M Sankelo, et al.
Deutsche Medizinische Wochenschrift (1946)|September 24, 2010
[Treatment of pulmonary arterial hypertension (PAH): recommendations of the Cologne Consensus Conference 2010]H A Ghofrani, O Distler, F Gerhardt, et al.
Pneumologie (Stuttgart, Germany)|December 19, 2001
[Recommendations for the choice of inhalatory systems for drug prescription]T Voshaar, E M App, D Berdel, et al.
Deutsche Medizinische Wochenschrift (1946)|December 10, 2014
[Supportive therapy in pulmonary arterial hypertension]E Grünig, N Ehlken, W Hohenforst-Schmidt, et al.
Deutsche Medizinische Wochenschrift (1946)|December 10, 2014
[Targeted therapy of pulmonary arterial hypertension (PAH)]H Klose, C Opitz, H Bremer, et al.
Wiener Klinisches Magazin : Beilage Zur Wiener Klinischen Wochenschrift|May 20, 2020
[Statement of the Austrian Society of Pneumology (ASP)]H Flick, B M Arns, J Bolitschek, et al.
Pageof 9